Invited oral presentation includes in vivo proof-of-concept data for AI-identified targeted therapies to be incorporated into ADCs to treat early-stage lung adenocarcinoma. CAMBRIDGE, MA / ACCESS ...

Overall, rates of new cancer diagnoses and cancer-related deaths have declined, according to the annual cancer statistics ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

According to the American Cancer Society, smoking tobacco is responsible for around 20 percent of all cancer cases and 30 ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient ...

Lung and bronchus cancer saw the biggest decline in cases, falling 3.4% per year. Six cancers saw an increase in diagnoses. Those included prostate, pancreas, oral cavity and pharynx, kidney and ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Most people in the U.S. have received vaccines to protect against infectious diseases. A vaccine against smallpox led to the ...

To diagnose lung cancer and determine the optimal treatment strategy, physicians typically rely on tissue examination. However, taking biopsies is ...

Nearly half of patients diagnosed with cancer in 2023 had a history of smoking, and 15% were smokers at the time of their ...